Catalent is a leading global CDMO, partnering with pharmaceutical, biotech, and self-care companies to accelerate the development, manufacturing, and delivery of life-changing therapies, and our Gene Therapy facility at the University of Maryland (UMD) BioPark in Baltimore, MD specializes in upstream and downstream viral vector process development for clinical programs, with advanced development labs and cGMP cleanroom suites supporting Phase 1 and 2 programs across AAV, vaccines, and oncolytic immunotherapies within a highly collaborative biotech and research hub. Catalent is an exciting and growing international company where employees work directly with pharma, biopharma and consumer health companies of all sizes to advance new medicines from early development to clinical trials and to the market.